Elmaparin
Application area
Prevention of thromboembolic complications:
- in general surgical and orthopedic interventions;
- in patients at high risk of thrombosis (in acute respiratory failure and/or respiratory infection, and/or heart failure), who are on bed rest due to an acute therapeutic pathology or hospitalised in resuscitation or intensive care units.
Treatment of moderate/severe pulmonary embolism or proximal deep vein thrombosis of lower extremities.
Prevention of blood clotting during hemodialysis.
Treatment of unstable angina and non-Q-wave myocardial infarction.
Application area
Direct acting anticoagulant
Composition:
Nadroparin calcium
1,900 anti-Xa IU syringe
2,850 anti-Xa IU syringe
3,800 anti-Xa IU syringe
4,750 anti-Xa IU syringe
5,700 anti-Xa IU syringe
6,650 anti-Xa IU syringe
7,600 anti-Xa IU syringe
1,900 anti-Xa IU ampoule
2,850 anti-Xa IU ampoule
3,800 anti-Xa IU ampoule
4,750 anti-Xa IU ampoule
5,700 anti-Xa IU ampoule
6,650 anti-Xa IU ampoule
7,600 anti-Xa IU ampoule
9,500 anti-Xa IU ampoule
Pre-filled syringes
